Ted Morton

Ted Morton is a Professor in the Department of Clinical Pharmacy and Translational Science at the University of Tennessee Health Science Center, College of Pharmacy. He serves as the Infectious Diseases Pharmacy Residency Director and is board certified in infectious diseases pharmacy (BCIDP). His clinical and research work is closely affiliated with St. Jude Children's Research Hospital, where he contributes to antimicrobial stewardship and pediatric infectious disease initiatives.

His research interests center on antimicrobial stewardship, pediatric infectious diseases, and pharmacotherapy in immunocompromised children. He has extensive expertise in optimizing antibiotic use, managing healthcare-associated infections, and guiding clinical responses to emerging pathogens like SARS-CoV-2 in vulnerable pediatric populations. His work often bridges clinical pharmacy practice with translational research to improve patient outcomes.

The recent publications reflect a strong focus on pediatric infectious disease management, particularly in oncology and immunocompromised settings. Themes include antimicrobial dosing (e.g., vancomycin), infection prevention, and evidence-based guidance for treating viral infections like COVID-19 in children. His collaborative work with national task forces underscores his role in shaping clinical guidelines.

Scientific Awards and Recognitions:

• Living Our Values award recipient, St. Jude Children's Research Hospital (2024)
• Clinical Care Improvement Award for Clinical Pharmacy Services, St. Jude (2020)
• Innovative Practice Award (Team), Tennessee Society of Health-System Pharmacists (2018)
• Excellence in Teaching Award, UT College of Pharmacy (2005)
• Teacher of the Year, P-2 Class, UT College of Pharmacy (2005)
• Residents’ Choice Award, UT Department of Medicine (2005)
• Preceptor of the Year, UT College of Pharmacy (2004)
• Pharmacist of the Year, Tennessee Society of Health-System Pharmacy (2003)

Ted Morton has played a significant role in clinical pharmacy education and residency training, evidenced by multiple teaching and preceptor awards. He advises pharmacy residents and contributes to curriculum development, particularly in infectious diseases. His work is supported through institutional affiliations and likely internal or collaborative grants related to antimicrobial stewardship and pediatric pharmacotherapy. He serves on key committees including the Antimicrobial Utilization and Improvement Committee and Infection Prevention and Control Committee at St. Jude.

Laboratories, Teams, and Collaborative Groups:

Dr. Morton collaborates extensively with multidisciplinary teams at St. Jude Children's Research Hospital and participates in national consortia such as the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists. He is a member of the Pediatric COVID-19 Therapies Taskforce and contributes to the American College of Clinical Pharmacy and the American Society of Health-System Pharmacists. His work is embedded within clinical teams focused on infection control, antimicrobial optimization, and pediatric pharmacotherapy.